BRIEF-Alexion Says No Compulsory License Of Soliris Was Requested Or Granted In Brazil By: Reuters: Company News April 20, 2018 at 15:40 PM EDT * ALEXION PROVIDES STATEMENT ON SUPERIOR COURT OF JUSTICE (STJ) DECISION IN BRAZIL INVOLVING SOLIRIS® (ECULIZUMAB) Read More >> Related Stocks: Alexion Pharmaceuticals